7L1G

PRMT5-MEP50 Complexed with SAM

Summary for 7L1G

• Entry DOI: 10.2210/pdb7l1g/pdb
• Descriptor: Protein arginine N-methyltransferase 5, Methylosome protein 50, 1,2-ETHANEDIOL, ... (6 entities in total)
• Functional Keywords: methyltransferase, transferase
• Biological source: Homo sapiens (Human); More
• Total number of polymer chains: 2
• Total formula weight: 113026.39

Authors

Palte, R.L. (deposition date: 2020-12-14, release date: 2021-04-14, Last modification date: 2024-10-23)

Primary citation

Candito, D.A.,Ye, Y.,Quiroz, R.V.,Reutershan, M.H.,Witter, D.,Gadamsetty, S.B.,Li, H.,Sauri, J.,Schneider, S.E.,Lam, Y.H.,Palte, R.L.
Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4- b ]furan Nucleoside Analogues.
J.Org.Chem., 86:5142-5151, 2021

PubMed Abstract: In the context of a PRMT5 inhibitor program, we describe our efforts to develop a flexible and robust strategy to access tetrahydrofuro[3,4-]furan nucleoside analogues. Ultimately, it was found that a Wolfe type carboetherification from an alkenol derived from d-glucofuranose diacetonide was capable of furnishing the B-ring and installing the desired heteroaryl group in a single step. Using this approach, key intermediate was delivered on a gram scale in a 62% yield and 9.1:1 dr in favor of the desired -isomer. After deprotection of , a late-stage glycosylation was performed under Mitsunobu conditions to install the pyrrolopyrimidine base. This provided serviceable yields of nucleoside analogues in the range of 31-48% yield. Compound was profiled in biochemical and cellular assays and was demonstrated to be a potent and cellularly active PRMT5 inhibitor, with a PRMT5-MEP50 biochemical IC of 0.8 nM, a MCF-7 target engagement EC of 3 nM, and a Z138 cell proliferation EC of 15 nM. This work sets the stage for the development of new inhibitors of PRMT5 and novel nucleoside chemical matter for alternate drug discovery programs.

PubMed: 33755465
DOI: 10.1021/acs.joc.0c02969

Experimental method

X-RAY DIFFRACTION (2.47 Å)